ArticleGraefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie2026
The impact of iCare HOME tonometry on clinical decision-making in glaucoma management: a retrospective observational study.
Article in Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo evaluate the impact of iCare HOME tonometry on clinical decision-making in the management of glaucomatous eyes with acceptable office IOPs but high-risk clinical features.
methodsThis retrospective study includes 82 eyes from 46 patients that had iCare HOME tonometry between 2020 and 2023. Patient demographics, ocular characteristics, iCare HOME data, prior surgical interventions and baseline medications, and changes to glaucoma management were collected. "IOP spike" was defined as any elevated iCare HOME measurement 5 mm Hg greater or 30% greater than the baseline office IOP. Physician impressions of visual field testing and optical coherence tomography imaging were also recorded to determine whether eyes had evidence of "glaucoma progression" prior to home tonometry. Statistical analyses were conducted to evaluate the factors influencing clinical decision making.
resultsThe 82 eyes in this study had generally normal office IOP and high-risk features on pre-home tonometry examination. 72% (59 eyes) of eyes demonstrated IOP spikes on home tonometry. Of eyes with home IOP spikes, 50.8% (30 eyes) had changes in their management. Eyes with management changes had higher trough home IOP (OR = 1.27 [1.04, 1.55], p = 0.017), better LogMAR BCVA (OR = 0.09 [0.02, 0.44], p = 0.003), and higher odds of glaucoma progression (OR = 2.59 [1.01, 6.61], p = 0.047). Among eyes without evidence of "glaucoma progression" but an "IOP spike" on home tonometry, a higher proportion of eyes did not have changes to their management (65.5% vs. 34.5%).
conclusionOur study found that 72% of eyes experienced a home IOP spike despite acceptable office IOPs, with roughly half of patients with home IOP spikes undergoing management changes. Among eyes with home IOP spikes but no evidence of glaucoma progression, a greater proportion had no management changes. These findings indicate that home IOP spikes are interpreted in the context of other clinical indicators, such as structural and functional imaging studies.
Indexed as
Identifiers
42848207What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.